Agenus Inc. (AGEN)
NASDAQ: AGEN · IEX Real-Time Price · USD
5.99
-1.31 (-17.95%)
At close: Jul 19, 2024, 4:00 PM
6.10
+0.11 (1.80%)
Pre-market: Jul 22, 2024, 8:02 AM EDT
Agenus Employees
Agenus had 389 employees as of December 31, 2023. The number of employees decreased by 144 or -27.02% compared to the previous year.
Employees
389
Change (1Y)
-144
Growth (1Y)
-27.02%
Revenue / Employee
$414,951
Profits / Employee
-$615,954
Market Cap
125.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Seer, Inc. | 147 |
X4 Pharmaceuticals | 93 |
Immunic | 77 |
Athira Pharma | 67 |
Relmada Therapeutics | 20 |
Annovis Bio | 16 |
Nuvectis Pharma | 13 |
Telomir Pharmaceuticals | 9 |
AGEN News
- 21 hours ago - Shareholders that lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about Securities Fraud Investigation - AGEN - Accesswire
- 22 hours ago - AGEN STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Agenus Inc. and Encourages Investors to Contact the Firm! - Accesswire
- 2 days ago - Levi & Korsinsky Announces an Investigation on Behalf of Agenus Inc. (AGEN) Shareholders Who May Have Been Affected by Fraud - Accesswire
- 2 days ago - Shareholder Rights Advocates at Levi & Korsinsky Investigate Agenus Inc. (AGEN) Regarding Possible Securities Fraud Violations - Accesswire
- 2 days ago - Investors Of Agenus Inc Have The Chance To Participate In The Securities Fraud Probe By The Schall Law Firm - Accesswire
- 2 days ago - AGEN ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Agenus Inc. - Accesswire
- 2 days ago - Agenus Faces Regulatory and Financial Challenges: Analyst Downgrades Stock Pending Trial Clarity - Benzinga
- 2 days ago - AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Agenus Inc. and Encourages Investors to Contact the Firm! - Accesswire